Medifast (MED) Stock Forecast and Price Target 2024 - MarketBeat

4 days ago · According to the 1 analysts' twelve-month price targets for Medifast, the average price target is $17.00. The highest price target for MED is $17.00, while the lowest price target for MED is $17.00. The average price target represents a forecasted downside of -13.13% from …

CouponFollow Extension

13%
OFF

Medifast (MED) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

marketbeat.com

$7326000
OFF

Medifast Inc Stock Forecast, Predictions & Price Target

1 week from now

Medifast. 's earnings in 2024 is $7,326,000.. On average, 2 Wall Street analysts forecast MED's earnings for 2024 to be $16,516,123, with the lowest MED earnings forecast at $13,016,018, …

wallstreetzen.com

$16
OFF

What Is The Current Price Target And Forecast For MEDIFAST (MED)

1 week from now

The forecasts for MEDIFAST INC (MED) range from a low of $16.5 to a high of $18. The average price target represents a decline of $7.16 from the last closing price of $18.58.

zacks.com

$17.50
OFF

Medifast (NYSE:MED) Stock, Analyst Ratings, Price Targets, Forecasts

1 week from now

The latest price target for Medifast (NYSE:MED) was reported by DA Davidson on July 22, 2024. The analyst firm set a price target for $17.50 expecting MED to fall to within 12 months (a …

benzinga.com

$16.50
OFF

Medifast (MED) Stock Forecast & Price Target - TipRanks

1 week from now

Based on 1 Wall Street analysts offering 12 month price targets for Medifast in the last 3 months. The average price target is $16.50 with a high forecast of $16.50 and a low forecast of $16.50. …

tipranks.com

$225.70
OFF

Zacks Research Has Bullish Estimate For ResMed Q2 Earnings

1 week from now

3 days ago · Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $225.70. Get Our Latest Research Report on …

marketbeat.com

$78.00
OFF

Boston Scientific Co. (NYSE:BSX) Shares Sold By ... - MarketBeat

1 week from now

1 day ago · Barclays raised their target price on shares of Boston Scientific from $78.00 to $86.00 and gave the stock an "overweight" rating in a research note on Thursday, August 22nd. TD …

marketbeat.com

$38.00
OFF

South Street Advisors LLC Raises Stock Position In Core

1 week from now

1 day ago · Bank of America dropped their target price on shares of Core & Main from $38.00 to $34.00 and set an "underperform" rating for the company in a report on Thursday, September …

marketbeat.com

$65.00
OFF

Analysts Issue Forecasts For CervoMed FY2024 Earnings - MarketBeat

1 week from now

2 days ago · Finally, Canaccord Genuity Group reaffirmed a "buy" rating and set a $65.00 price target on shares of CervoMed in a research note on Thursday, July 25th. Five investment …

marketbeat.com

FAQs about Medifast (MED) Stock Forecast and Price Target 2024 - MarketBeat Coupon?

How did Medifast's stock perform in 2024?

Medifast's stock was trading at $67.22 at the beginning of 2024. Since then, MED shares have decreased by 70.6% and is now trading at $19.76. View the best growth stocks for 2024 here. How were Medifast's earnings last quarter? Medifast, Inc. (NYSE:MED) posted its quarterly earnings data on Monday, August, 5th. ...

Is Medifast a good stock to buy?

Medifast has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating. Medifast has only been the subject of 1 research reports in the past 90 days. Read more about Medifast's stock forecast and price target. ...

What is the target price for Medifast?

The 10 analysts offering price forecasts for Medifast have a median target of 62.60, with a high estimate of 106.00 and a low estimate of 17.50. The median estimate represents a 29.58 difference from the last price of 18.52. ...

How far is Medifast stock from the 52-week low?

The low in the last 52 weeks of Medifast stock was 17.10. According to the current price, Medifast is 108.30% away from the 52-week low. What was the 52-week high for Medifast stock? The high in the last 52 weeks of Medifast stock was 76.44. According to the current price, Medifast is 24.23% away from the 52-week high. ...

How many Medifast shares have been sold short?

The latest short interest is 2.94 million, so 26.88% of the outstanding shares have been sold short. In the last 12 months, Medifast had revenue of $897.81 million and earned $67.76 million in profits. Earnings per share was $6.20. ...

What is the consensus rating for Medifast (med) stock?

The consensus rating is "Sell". This stock does not have any record of stock splits. Medifast has an Altman Z-Score of 6.63 and a Piotroski F-Score of 7. Detailed statistics for Medifast, Inc. (MED) stock, including valuation metrics, financial numbers, share information and more. ...